142 related articles for article (PubMed ID: 8104936)
1. A role for the interchain disulfide or its participating thiols in the internalization of botulinum neurotoxin A revealed by a toxin derivative that binds to ecto-acceptors and inhibits transmitter release intracellularly.
de Paiva A; Poulain B; Lawrence GW; Shone CC; Tauc L; Dolly JO
J Biol Chem; 1993 Oct; 268(28):20838-44. PubMed ID: 8104936
[TBL] [Abstract][Full Text] [Related]
2. Multiple domains of botulinum neurotoxin contribute to its inhibition of transmitter release in Aplysia neurons.
Poulain B; Wadsworth JD; Shone CC; Mochida S; Lande S; Melling J; Dolly JO; Tauc L
J Biol Chem; 1989 Dec; 264(36):21928-33. PubMed ID: 2574722
[TBL] [Abstract][Full Text] [Related]
3. Neurotransmitter release is blocked intracellularly by botulinum neurotoxin, and this requires uptake of both toxin polypeptides by a process mediated by the larger chain.
Poulain B; Tauc L; Maisey EA; Wadsworth JD; Mohan PM; Dolly JO
Proc Natl Acad Sci U S A; 1988 Jun; 85(11):4090-4. PubMed ID: 2897693
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of transmitter release by botulinum neurotoxin A. Contribution of various fragments to the intoxication process.
Poulain B; Wadsworth JD; Maisey EA; Shone CC; Melling J; Tauc L; Dolly JO
Eur J Biochem; 1989 Oct; 185(1):197-203. PubMed ID: 2572418
[TBL] [Abstract][Full Text] [Related]
5. Reductive chain separation of botulinum A toxin--a prerequisite to its inhibitory action on exocytosis in chromaffin cells.
Stecher B; Gratzl M; Ahnert-Hilger G
FEBS Lett; 1989 May; 248(1-2):23-7. PubMed ID: 2721679
[TBL] [Abstract][Full Text] [Related]
6. Differences in the multiple step process of inhibition of neurotransmitter release induced by tetanus toxin and botulinum neurotoxins type A and B at Aplysia synapses.
Poulain B; De Paiva A; Deloye F; Doussau F; Tauc L; Weller U; Dolly JO
Neuroscience; 1996 Jan; 70(2):567-76. PubMed ID: 8848160
[TBL] [Abstract][Full Text] [Related]
7. Productive and non-productive binding of botulinum neurotoxin A to motor nerve endings are distinguished by its heavy chain.
Daniels-Holgate PU; Dolly JO
J Neurosci Res; 1996 May; 44(3):263-71. PubMed ID: 8723765
[TBL] [Abstract][Full Text] [Related]
8. Involvement of the constituent chains of botulinum neurotoxins A and B in the blockade of neurotransmitter release.
Maisey EA; Wadsworth JD; Poulain B; Shone CC; Melling J; Gibbs P; Tauc L; Dolly JO
Eur J Biochem; 1988 Nov; 177(3):683-91. PubMed ID: 3197726
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of neurotransmitter release by botulinum neurotoxins and tetanus toxin at Aplysia synapses: role of the constituent chains.
Poulain B; Mochida S; Wadsworth JD; Weller U; Habermann E; Dolly JO; Tauc L
J Physiol (Paris); 1990; 84(4):247-61. PubMed ID: 1981913
[TBL] [Abstract][Full Text] [Related]
10. Heterologous combinations of heavy and light chains from botulinum neurotoxin A and tetanus toxin inhibit neurotransmitter release in Aplysia.
Poulain B; Mochida S; Weller U; Högy B; Habermann E; Wadsworth JD; Shone CC; Dolly JO; Tauc L
J Biol Chem; 1991 May; 266(15):9580-5. PubMed ID: 1674511
[TBL] [Abstract][Full Text] [Related]
11. Minimal essential domains specifying toxicity of the light chains of tetanus toxin and botulinum neurotoxin type A.
Kurazono H; Mochida S; Binz T; Eisel U; Quanz M; Grebenstein O; Wernars K; Poulain B; Tauc L; Niemann H
J Biol Chem; 1992 Jul; 267(21):14721-9. PubMed ID: 1634516
[TBL] [Abstract][Full Text] [Related]
12. Reductive cleavage of tetanus toxin and botulinum neurotoxin A by the thioredoxin system from brain. Evidence for two redox isomers of tetanus toxin.
Kistner A; Habermann E
Naunyn Schmiedebergs Arch Pharmacol; 1992 Feb; 345(2):227-34. PubMed ID: 1570025
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of neurotransmitter release by peptides that mimic the N-terminal domain of SNAP-25.
Apland JP; Adler M; Oyler GA
J Protein Chem; 2003 Feb; 22(2):147-53. PubMed ID: 12760419
[TBL] [Abstract][Full Text] [Related]
14. Peptides that mimic the carboxy-terminal domain of SNAP-25 block acetylcholine release at an Aplysia synapse.
Apland JP; Biser JA; Adler M; Ferrer-Montiel AV; Montal M; Canaves JM; Filbert MG
J Appl Toxicol; 1999 Dec; 19 Suppl 1():S23-6. PubMed ID: 10594895
[TBL] [Abstract][Full Text] [Related]
15. Interaction of 125I-labeled botulinum neurotoxins with nerve terminals. I. Ultrastructural autoradiographic localization and quantitation of distinct membrane acceptors for types A and B on motor nerves.
Black JD; Dolly JO
J Cell Biol; 1986 Aug; 103(2):521-34. PubMed ID: 3733877
[TBL] [Abstract][Full Text] [Related]
16. Isolated light chains of botulinum neurotoxins inhibit exocytosis. Studies in digitonin-permeabilized chromaffin cells.
Bittner MA; DasGupta BR; Holz RW
J Biol Chem; 1989 Jun; 264(18):10354-60. PubMed ID: 2732226
[TBL] [Abstract][Full Text] [Related]
17. Covalent structure of botulinum neurotoxin type A: location of sulfhydryl groups, and disulfide bridges and identification of C-termini of light and heavy chains.
Krieglstein KG; DasGupta BR; Henschen AH
J Protein Chem; 1994 Jan; 13(1):49-57. PubMed ID: 8011071
[TBL] [Abstract][Full Text] [Related]
18. Intracellularly injected tetanus toxin inhibits exocytosis in bovine adrenal chromaffin cells.
Penner R; Neher E; Dreyer F
Nature; 1986 Nov 6-12; 324(6092):76-8. PubMed ID: 3785374
[TBL] [Abstract][Full Text] [Related]
19. A Heterologous Reporter Defines the Role of the Tetanus Toxin Interchain Disulfide in Light-Chain Translocation.
Zuverink M; Chen C; Przedpelski A; Blum FC; Barbieri JT
Infect Immun; 2015 Jul; 83(7):2714-24. PubMed ID: 25895970
[TBL] [Abstract][Full Text] [Related]
20. [Ganglionic synapses of Aplysia as a model for the study of the mechanism of action of botulinum neurotoxins].
Poulain B; Tauc L; Maisey EA; Dolly JO
C R Acad Sci III; 1988; 306(15):483-8. PubMed ID: 2900674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
